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A corrigendum on:
Progress in antiandrogen design targeting hormone binding pocket to circumvent mutation
based resistance
by Tian, X., He, Y., and Zhou, J. (2015). Front. Pharmacol. 6:57. doi: 10.3389/fphar.2015.00057
In the version of this article initially published online, there are two typos in Figure 3B, the
“Atiandrogen design” should be “Antiandrogen design” and “ZINK” should be “ZINC.” The
correction has no impact on the results of the study or its conclusions. The corrected figure is
given here.
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FIGURE 3 | Rational antiandrogen design strategy to combat the mutation driven drug resistance. (A) Bulky group strategy. (B) Structure based
antiandrogen design. (C) Conjugate strategy.
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